科研动态PubMed 摘要

靶向微生物组的阿尔茨海默病策略:多组学特征、机制联系与干预证据。

PubMed 白名单日捞 · 2026-10-28

完整摘要 · 中文译文

阿尔茨海默病(AD)与肠道微生物机制的关系日益受到研究,因为微生物代谢、黏膜屏障功能和外周免疫激活可能影响神经炎症和宿主代谢应激。本综述评估了AD中与微生物组相关的证据,重点纳入结合宏基因组学、代谢组学、炎症标志物、神经影像学、脑脊液或血液生物标志物以及认知表型分析的研究。现有数据支持若干反复出现但尚未确立因果关系的轴线,包括胆汁酸转化、短链脂肪酸(SCFA)产生、氧化三甲胺(TMAO)、细菌产物相关炎症信号以及屏障功能障碍。我们还综述了微生物组靶向干预措施,包括饮食和益生元、菌株特异性益生菌和合生元、基于寡糖的制剂、肠道限制性抗菌药物以及粪菌移植(FMT)。这些策略的证据强度差异显著:甘露寡糖二酸已在3期试验中接受检验,而许多益生菌、抗菌药物和FMT方法仍处于早期临床、临床前或机制探索阶段。未来试验应预先设定微生物、代谢物、免疫和脑生物标志物终点;控制饮食、药物和合并症混杂因素;并在将微生物组特征用于筛查或治疗选择之前,在独立队列中验证候选特征谱。

完整摘要 · 英文原文

Alzheimer's disease (AD) is increasingly studied in relation to gut microbial mechanisms because microbial metabolism, mucosal barrier function, and peripheral immune activation may influence neuroinflammation and host metabolic stress. This review evaluates microbiome-linked evidence in AD with emphasis on studies that combine metagenomics, metabolomics, inflammatory markers, neuroimaging, cerebrospinal fluid or blood biomarkers, and cognitive phenotyping. Current data support several recurring but not yet causal axes, including bile acid transformation, short-chain fatty acid (SCFA) production, trimethylamine N-oxide (TMAO), bacterial product-related inflammatory signaling, and barrier dysfunction. We also review microbiome-targeted interventions, including diet and prebiotics, strain-specified probiotics and synbiotics, oligosaccharide-based agents, gut-restricted antimicrobials, and fecal microbiota transplantation (FMT). The strength of evidence differs substantially across these strategies: sodium oligomannate has been tested in a phase 3 trial, whereas many probiotic, antimicrobial, and FMT approaches remain early clinical, preclinical, or mechanism-generating. Future trials should define a priori microbial, metabolite, immune, and brain biomarker endpoints; control diet, medication, and comorbidity confounding; and validate candidate signatures across independent cohorts before using microbiome profiles for screening or treatment selection.

English
Microbiome-targeted strategies for Alzheimer's disease: multi-omics signatures, mechanistic links, and intervention evidence.
内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界